Nasdaq:IMRN

Immuron Reports Continued Sales Growth

Sales Highlights (unaudited): Global H1 sales AUD$4.2 million up 5% on prior comparative period (pcp)Q2 sales AUD$2.2 million up 11%…

4 hours ago